Abstract
Candida albicans is an opportunistic fungal able to produces both superficial and systemic infections in immunocompromised patients. It has been shown that, comparing to the planktonic form, the C. albicans biofilms have different resistance to antifungal drugs and that infections related to biofilm formation are often refractory to conventional therapies. Therefore, the development of mo…